[

university of oxford

]
PAGE 2

Delhi based student lands research internship offer from over 10 world famous universities

At times, these dreams get dashed at the selection level of some top-notch universities as students are not passed-out from renowned institutions.
Delhi-based Abhishek Agrahari, an engineering student,received internship offers from the UK’s University of Oxford and the USA’s Pennsylvania State University and the University of Illinois, among others.(ANI)
Delhi-based Abhishek Agrahari, an engineering student,received internship offers from the UK’s University of Oxford and the USA’s Pennsylvania State University and the University of Illinois, among others.(ANI)
Updated on Oct 27, 2020 05:15 PM IST
Copy Link
New Delhi | ByAsian News International| Posted by Akhilesh Nagari

Oxford vaccine tests raise hopes

British health secretary Matt Hancock said a vaccine was not yet ready but he was preparing logistics for a possible roll-out mostly in the first half of 2021
A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people.(REUTERS)
A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people.(REUTERS)
Updated on Oct 27, 2020 04:30 AM IST
Copy Link
London/Paris | ByAgencies

Oxford Covid-19 vaccine trials produce robust immune response in elderly

The Covid-19 vaccine being developed by the University of Oxford and AstraZeneca Plc produces a robust immune response in elderly people, the Financial Times said on Monday, citing early results.
A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people, hammered the global economy and shuttered normal life across the world.(File photo for representation)
A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people, hammered the global economy and shuttered normal life across the world.(File photo for representation)
Updated on Oct 26, 2020 06:39 PM IST
Copy Link
London | ByReuters | Posted by Niyati Singh

AstraZeneca’s Covid-19 vaccine seen effective in elderly people: Report

The Financial Times report, citing two unidentified people familiar with the finding, said that the vaccine which the company is manufacturing has produced protective antibodies and T-cells in those belonging to the older age groups.
AstraZeneca is producing the vaccine in collaboration with the University of Oxford.(Reuters file photo)
AstraZeneca is producing the vaccine in collaboration with the University of Oxford.(Reuters file photo)
Updated on Oct 26, 2020 12:06 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com| Edited by: Harshit Sabarwal

Oxford’s Brazil vaccine trial to continue, says university after volunteer dies

“Following careful assessment of this case in Brazil, there have been no concerns about safety of the clinical trial and the independent review in addition to the Brazilian regulator have recommended that the trial should continue,” a spokesman for the university said in a statement.
A chemist works at AstraZeneca's headquarters.(Reuters)
A chemist works at AstraZeneca's headquarters.(Reuters)
Updated on Oct 22, 2020 12:30 AM IST
Copy Link
Reuters | ByReuters | Posted by Shivani Kumar

British Covid-19 testing adviser calls for ‘circuit-breaker’ lockdown

On Tuesday, Britain’s opposition Labour Party called for a two- to three-week lockdown across England, though it wants schools to stay open.
On Friday, more data suggested that England was still seeing a sharp rise in cases.(Pratham Gokhale/HT Photo)
On Friday, more data suggested that England was still seeing a sharp rise in cases.(Pratham Gokhale/HT Photo)
Published on Oct 17, 2020 04:30 PM IST
Copy Link
London | ByReuters| Posted by Susmita Pakrasi

Oxford scientists develop 5-minute Covid-19 antigen test

The university said it hoped to start product development of the testing device in early 2021 and have an approved device available six months afterwards.
Scientists from Britain’s University of Oxford have developed a rapid Covid-19 test able to identify the coronavirus in less than five minutes(REUTERS)
Scientists from Britain’s University of Oxford have developed a rapid Covid-19 test able to identify the coronavirus in less than five minutes(REUTERS)
Updated on Oct 15, 2020 04:10 PM IST
Copy Link
Reuters | ByReuters| Posted by Susmita Pakrasi

UK seeks non-white volunteers for Covid-19 vaccine trials

The non-white community has been disproportionately affected by coronavirus pandemic, prompting the government to launch an inquiry. Currently the community is under-represented in six vaccine clinical trials taking place across the UK.
An AstraZeneca's chemist works in a lab in Australia.(Reuters file)
An AstraZeneca's chemist works in a lab in Australia.(Reuters file)
Updated on Oct 13, 2020 06:08 PM IST
Copy Link
Hindustan Times, London | ByPrasun Sonwalkar

Royal honours for Indian-origin Covid-19 heroes

Prime Minister Boris Johnson said the recipients were “a testament to the sort of country we are - caring, compassionate and resolute in the face of a global pandemic. The hard work and dedication of these local, often unsung heroes has helped carry us through”.
A sign reading
A sign reading "Covid-19 Keep Apart", sits on a temporary protective pedestrian barrier on Oxford Street in central London, U.K., on Thursday, Oct. 1, 2020. The City of London's traffic-lite streets look set to outlast the pandemic.(Bloomberg)
Published on Oct 10, 2020 07:31 AM IST
Copy Link
Hindustan Times, London | ByPrasun Sonwalkar

Oxford University Covid-19 vaccine could be rolled out within 6 months: Report

The vaccine candidate under trial by University of Oxford scientists in collaboration with pharmaceutical giant AstraZeneca is the furthest in the process of trials and, according to a report in ‘The Times’, it could be given the required clearances by Christmas in December.
“We are looking at closer to six months and it is likely to be far shorter than that,” a government source said.(Reuters image)
“We are looking at closer to six months and it is likely to be far shorter than that,” a government source said.(Reuters image)
Updated on Oct 03, 2020 06:46 PM IST
Copy Link
London | ByPress Trust of India | Posted by Prashasti Singh

Oxford-Astra Covid vaccine review to start in Europe

The death toll from the disease exceeded 1 million this week, while the infection rate has rapidly picked up again in Europe.
While the British regulator cleared the Oxford-Astra trial to restart less than a week after it was paused and studies in South Africa, Brazil and India have resumed, US authorities have yet to give the go-ahead.(REUTERS)
While the British regulator cleared the Oxford-Astra trial to restart less than a week after it was paused and studies in South Africa, Brazil and India have resumed, US authorities have yet to give the go-ahead.(REUTERS)
Published on Oct 01, 2020 05:28 AM IST
Copy Link
Bloomberg | ByBloomberg| Posted by Susmita Pakrasi

EU regulator backs dexamethasone as Covid-19 treatment

The European Medicines Agency (EMA) said on Friday the drug could be an option to treat adults and adolescents needing oxygen therapy or mechanical ventilation, after concluding its review of results from a trial by British scientists.
The drug has since been approved in Japan as a Covid-19 treatment.(PTI)
The drug has since been approved in Japan as a Covid-19 treatment.(PTI)
Published on Sep 18, 2020 08:14 PM IST
Copy Link
Reuters | ByReuters| Posted by Susmita Pakrasi

AstraZeneca’s Covid-19 vaccine trial in US remains on hold pending FDA review

Temporary pauses in clinical trials aren’t unusual. However, the reported event has heightened worry that the global campaign to find a Covid-19 vaccine is moving too quickly. AstraZeneca is among several drugmakers who have agreed to work with and supply shots to Operation Warp Speed.
A test tube labelled with the Vaccine is seen in front of AstraZeneca logo(Reuters File Photo)
A test tube labelled with the Vaccine is seen in front of AstraZeneca logo(Reuters File Photo)
Updated on Sep 17, 2020 12:07 AM IST
Copy Link
ByBloomberg | Posted by Kanishka Sarkar

Researchers trial inhaled versions of Oxford and Imperial Covid-19 vaccine candidates

The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.
Trials of the Oxford vaccine, which has been licensed to AstraZeneca, resumed at the weekend after safety watchdogs gave it the go-ahead. Late-stage trials had been paused after study subject fell in Britain.(REUTERS)
Trials of the Oxford vaccine, which has been licensed to AstraZeneca, resumed at the weekend after safety watchdogs gave it the go-ahead. Late-stage trials had been paused after study subject fell in Britain.(REUTERS)
Published on Sep 15, 2020 10:42 AM IST
Copy Link
Reuters | ByReuters| Posted by Susmita Pakrasi

AstraZeneca still aiming for Covid-19 vaccine by year-end, CEO says

“What we have here is a special set of circumstances where the whole world becomes involved in the conduct of a clinical trial,” AstraZeneca Plc Chief Executive Officer Pascal Soriot said in his first public comments since the trial was halted.
A volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg. This is part of Africa's first participation in a COVID-19 vaccine trial developed at the University of Oxford in Britain in conjunction with the pharmaceutical company AstraZeneca. (Siphiwe Sibeko/Pool via AP)
A volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg. This is part of Africa's first participation in a COVID-19 vaccine trial developed at the University of Oxford in Britain in conjunction with the pharmaceutical company AstraZeneca. (Siphiwe Sibeko/Pool via AP)
Updated on Sep 10, 2020 08:25 PM IST
Copy Link
ByBloomberg

AstraZeneca pauses Covid-19 vaccine trial just after 9 drug makers take safety pledge

The move comes amid a growing perception that despite his claims to the contrary, US President Donald Trump is rushing the search for a vaccine breakthrough before November 3, the election day, to help him win a second term.
A man walks past a sign at an AstraZeneca site in Macclesfield, central England(REUTERS)
A man walks past a sign at an AstraZeneca site in Macclesfield, central England(REUTERS)
Updated on Sep 09, 2020 10:10 PM IST
Copy Link
Hindustan Times, Washington | ByYashwant Raj

Oxford Covid vaccine data could go before regulators this year: Director

The Oxford vaccine showed early promise in the first human trial when it produced an immune response, underlining its position as one of the leading candidates in the race to produce a vaccine against the coronavirus disease (Covid-19).
SII is the world’s largest vaccine manufacturer by the number of doses produced and sold globally.(AP)
SII is the world’s largest vaccine manufacturer by the number of doses produced and sold globally.(AP)
Updated on Aug 25, 2020 06:56 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com| Edited by Susmita Pakrasi

Covid-19: Rise in kids attacking parents in UK lockdown

Caroline Miles of the University of Manchester noted that many children who are violent towards their parents have safeguarding needs of their own, having experience trauma of some kind themselves, and/or have mental health problems, learning difficulties, or additional needs.
A commuter wearing a protective face mask crosses Westminster Bridge in view of the Houses of Parliament and Elizabeth Tower, also known as Big Ben, in London, UK.(Bloomberg File Photo)
A commuter wearing a protective face mask crosses Westminster Bridge in view of the Houses of Parliament and Elizabeth Tower, also known as Big Ben, in London, UK.(Bloomberg File Photo)
Updated on Aug 20, 2020 01:02 AM IST
Copy Link
Hindustan Times, London | ByPrasun Sonwalkar

UK relaxes more Covid-19 curbs, mask violators face £3,200 fine

The enforcement measures include doubling the fine to a maximum of £3,200 for those who repeatedly flout face covering rules, and new fines introduced for people hosting raves or other unlawful gatherings of more than 30 people.
A bus passenger wears a mask, amid the coronavirus disease (Covid-19) outbreak, in London, Britain.(REUTERS)
A bus passenger wears a mask, amid the coronavirus disease (Covid-19) outbreak, in London, Britain.(REUTERS)
Published on Aug 14, 2020 02:25 PM IST
Copy Link
Hindustan Times, London | ByPrasun Sonwalkar

Oxford launches literary book club to help deal with Covid-19

As lockdowns and restrictions in various countries encourage many to dust-off old books and revel in the delights of literature, the University of Oxford on Tuesday launched a book club that will weekly release a selected book extract that could be read in 10 minutes.
The extracts, they said, will include books by Indian writers, among others, and from a wide selection of genres, such as novels, essays, poetry and short stories.(File photo for representation)
The extracts, they said, will include books by Indian writers, among others, and from a wide selection of genres, such as novels, essays, poetry and short stories.(File photo for representation)
Updated on Aug 11, 2020 05:57 PM IST
Copy Link
Hindustan Times, London | ByPrasun Sonwalkar

China firm to make 100 million doses of potential UK Covid-19 vaccine by 2020 end

The potential coronavirus vaccine developed by the company with Oxford University has produced a promising immune response in a large, early-stage human trial, medical journal The Lancet said in a report in July.
The vaccine deal is the first to cater to China, the most populous country in the world, the statements said.(REUTERS)
The vaccine deal is the first to cater to China, the most populous country in the world, the statements said.(REUTERS)
Updated on Aug 06, 2020 08:38 PM IST
Copy Link
Hindustan Times, Beijing | BySutirtho Patranobis

Decoding Oxford’s Covid-19 vaccine results and why they offer hope

AstraZeneca Chief Executive Pascal Soriot said the company hopes the vaccine will be available this year depending on how quickly late-stage trials can be completed.
A general view of AstraZeneca offices and the corporate logo in Cambridge, England.(AP File Photo)
A general view of AstraZeneca offices and the corporate logo in Cambridge, England.(AP File Photo)
Updated on Jul 21, 2020 11:47 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by: Amit Chaturvedi

Oxford-Astra Covid-19 vaccine shows dual immune action, says researcher

The AstraZeneca Plc Covid-19 vaccine increased levels of both protective neutralizing antibodies and immune T-cells that target the virus, according to the study organizers.
A health worker sanitizes the doorway as doctors come out from a Covid-19 care centre functioning in an indoor stadium in New Delhi on Monday.(AP Photo)
A health worker sanitizes the doorway as doctors come out from a Covid-19 care centre functioning in an indoor stadium in New Delhi on Monday.(AP Photo)
Updated on Jul 20, 2020 07:49 PM IST
Copy Link
ByBloomberg | Posted by Kanishka Sarkar

Oxford’s Covid-19 vaccine candidate is safe, early results show

The Lancet said the current trial is too preliminary to confirm whether the new vaccine meets these requirements, but phase 2 (in the UK only) and phase 3 trials to confirm whether it effectively protects against SARS-CoV-2 infection are happening in the UK, Brazil and South Africa.
In this handout photo released by the University of Oxford samples from coronavirus vaccine trials are handled inside the Oxford Vaccine Group laboratory in Oxford.(AP)
In this handout photo released by the University of Oxford samples from coronavirus vaccine trials are handled inside the Oxford Vaccine Group laboratory in Oxford.(AP)
Updated on Jul 20, 2020 07:57 PM IST
Copy Link
Hindustan Times, London | ByPrasun Sonwalkar

British PM Boris Johnson dampens hopes of Covid-19 vaccine this year

Johnson’s comments came soon after Business secretary Alok Sharma announced new deals to secure early access to three promising Covid-19 vaccine candidates.
Britain's Prime Minister Boris Johnson during a visit to The Discovery School in Kent, Britain on July 20, 2020.(Reuters Photo)
Britain's Prime Minister Boris Johnson during a visit to The Discovery School in Kent, Britain on July 20, 2020.(Reuters Photo)
Updated on Jul 20, 2020 05:06 PM IST
Copy Link
Hindustan Times, London | ByPrasun Sonwalkar

Over 80k new cases since Monday in India; AstraZeneca, Moderna emerge as top vaccine contenders: Covid-19 week wrap

On Monday morning, the national Covid-19 tally was updated to 425,282 which stood at 508,953 on Saturday morning - an increase of 83,671 new cases.
Medics wait for people at a coronavirus rapid antigen testing facility in a health centre in New Delhi.(Arvind Yadav/HT PHOTO)
Medics wait for people at a coronavirus rapid antigen testing facility in a health centre in New Delhi.(Arvind Yadav/HT PHOTO)
Updated on Jun 27, 2020 11:44 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Sparshita Saxena

16 vaccines against Covid-19 enter clinical evaluation stage, 125 candidates in preclinical evaluation: WHO’s draft landscape

The University of Oxford and AstraZeneca Plc.’s experimental vaccine, ChAdOx1-S, has become the first to enter the final stages of clinical trials against the coronavirus disease.
A volunteer receives an injection from a medical worker during the country's first human clinical trial for a potential vaccine against the novel coronavirus, at the Baragwanath hospital in Soweto, South Africa.(REUTERS)
A volunteer receives an injection from a medical worker during the country's first human clinical trial for a potential vaccine against the novel coronavirus, at the Baragwanath hospital in Soweto, South Africa.(REUTERS)
Updated on Jun 25, 2020 02:20 PM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Sparshita Saxena

Oxford platform to accelerate Covid-19 tests into use

The 1.3-million pound ($1.6-million) research program seeks to bring together experts who are “highly experienced in evaluating diagnostic tests and generating the robust evidence required” for a test to be used in the U.K.’s National Health Service.
The Covid-19 National DiagnOstic Research and Evaluation Platform, or CONDOR, will create a single national route for evaluating new diagnostic tests in hospitals(AP)
The Covid-19 National DiagnOstic Research and Evaluation Platform, or CONDOR, will create a single national route for evaluating new diagnostic tests in hospitals(AP)
Published on Jun 24, 2020 05:26 PM IST
Copy Link
Bloomberg | ByBloomberg

Covid-19: Imperial College London’s vaccine human trial begins

Over the coming weeks, 300 healthy participants are expected to receive two doses of the vaccine. If the vaccine is safe and shows a promising immune response in humans, then larger trials would be planned for later in the year.
In the initial stage of the trial, 15 healthy volunteers are receiving the vaccine – starting with a low dose and escalating to increasingly higher doses for subsequent volunteers – to assess safety and to find the optimal dosage.(AP)
In the initial stage of the trial, 15 healthy volunteers are receiving the vaccine – starting with a low dose and escalating to increasingly higher doses for subsequent volunteers – to assess safety and to find the optimal dosage.(AP)
Updated on Jun 24, 2020 12:58 AM IST
Copy Link
Hindustan Times, London | ByPrasun Sonwalkar

Pig trial of AstraZeneca’s Covid-19 vaccine shows promise with two shots

The ChAdOx1 nCoV-19 vaccine was originally developed by researchers at the University of Oxford, who are now working with AstraZeneca on development and production.
The vaccine is already in mid-stage human trials, and AstraZeneca has said it hopes to have data showing efficacy later this year.(REUTERS)
The vaccine is already in mid-stage human trials, and AstraZeneca has said it hopes to have data showing efficacy later this year.(REUTERS)
Published on Jun 23, 2020 03:00 PM IST
Copy Link
London | ByReuters| Posted by Susmita Pakrasi
SHARE
  • 1
  • 2
  • 3
  • ...
Story Saved
×
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Tuesday, December 07, 2021